- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Sun Pharma Advanced Research Center to Use FEI Cryo-Electron Microscopy Solution to Obtain Particle Structure and Function Information
FEI Company (Nasdaq: FEIC), a leading provider of high-resolution imaging and analysis systems, announced today the installation of a solution based upon FEI's Tecnai™ Spirit cryo-transmission electron microscope (TEM) and three-dimensional (3D) tomography software at Sun Pharmaceutical Industries, Ltd. (Bombay Stock Exchange: SUN), Mumbai, India. Sun Pharmaceutical will use FEI's 3D imaging solution for quality control of drug-loaded vesicles to speed up the development of new therapeutics.
"The cost of developing drugs and bringing new products to market is enormous and rising yearly; having access to accurate and timely information is essential for making decisions on compounds in our pipeline," said Dr. Subhas Bhowmick, vice president formulation development, Sun Pharmaceutical. "We will use the FEI 3D imaging solution to gain a better understanding of the behavior of the drug in the human body in an effort to develop therapeutics that not only are more effective, but also exhibit reduced side effects. The information will also help us to shorten the drug development process and bring new therapeutics to market faster."
Cryo-TEM allows life science researchers to study biological systems in their native, hydrated state and obtain unique information about the particle structure and function. Other (non-cryo) microscopy and preparation techniques can damage the fragile biological sample and do not preserve the structure needed for 3D reconstruction information. FEI's tomography software allows for the system's automation to acquire and process thousands of images unattended. FEI's 3D imaging solution can also aid in the pharmaceutical production process; for example, new drug delivery techniques, such as encapsulating a drug in a liposome, can be monitored during production by visualizing the particle. These new drug delivery techniques utilize labeled liposomes that are transferred directly to the site of interest (such as a tumor cell) and enable targeted delivery of drugs without harming healthy tissue.
"We are pleased that Sun Pharmaceutical, one of India's largest and most innovative pharmaceutical companies, has invested in FEI's 3D imaging solution with the Tecnai Spirit TEM and tomography software package. The system will be used for research on some very exciting drug delivery systems, and we look forward to providing our support and expertise in this area," said Matthew Harris, vice president and general manager of FEI's Life Science Division. "FEI is an ideal partner for ultra-structural investigation of small particles like proteins, viruses, liposomes, etc., and our solutions are specifically designed for the unique requirements of high-resolution life science imaging."
Sun Pharmaceutical is an international pharmaceutical company that makes many generic and brand name drugs for worldwide distribution. Sun manufactures both pharmaceuticals and active pharmaceutical ingredients (API), and its products are used in several therapeutic areas, including oncology, psychiatry, neurology, cardiology, diabetology, gastroenterology, respiratory and orthopedics. FEI's 3D imaging solution has been installed in the Sun Pharma Advanced Research Centre located in Vadodara, Gujarat, India.
About FEI Company
FEI (Nasdaq: FEIC) is the world leader in pioneering technologies and applications that deliver imaging solutions for 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Ångström level. Our customers, working in advanced research and manufacturing, are supported by field-experienced applications specialists. They have open access to FEI’s prestigious global user network so they can succeed in accelerating nanoscale discovery and contribute to better living through new product commercialization. FEI’s NanoPorts in North America, Europe and Asia provide centers of technical excellence where our world-class community of customers and specialists collaborate on the ongoing development of new ideas and innovative solutions. FEI has sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.
FEI Safe Harbor Statement
This press release contains forward-looking statements about the installation of FEI systems and software at Sun Pharmaceutical and their potential benefits. Factors that could affect these forward-looking statements include, but are not limited to, failure of the system to perform as expected and achieve anticipated benefits. Please also refer to the company’s Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on this and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update any forward-looking statements.
The FEI logo and Tecnai are trademarks of FEI Company.
For more information, please click here
Fletcher Chamberlin (investors and analysts)
MindWrite Communications, Inc
Sandy Fewkes, Principal
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Stanford breakthrough heralds super-efficient light-based computers: Light can transmit more data while consuming far less power than electricity, and an engineering feat brings optical data transport closer to replacing wires May 29th, 2015
Two UCSB Professors Receive Early Career Research Awards: The Department of Energy’s award for young scientists acknowledges UC Santa Barbara’s standing as a top tier research institution May 29th, 2015
Nano-capsules designed for diagnosing malignant tumours: Japanese researchers have developed adaptable nano-capsules that can help in the diagnosis of glioblastoma cells - a highly invasive form of brain tumours May 28th, 2015
Physicists solve quantum tunneling mystery: ANU media release: An international team of scientists studying ultrafast physics have solved a mystery of quantum mechanics, and found that quantum tunneling is an instantaneous process May 27th, 2015
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015
FEI Partners With the George Washington University to Equip New Science & Engineering Hall: Suite of new high-performance microscopes will be used for cutting-edge experiments at GW’s new research facility April 29th, 2015